Andere Kunden interessierten sich auch für
![DENTAL MANAGEMENT OF PATIENTS WITH ANTICOAGULANT THERAPY]( "DENTAL MANAGEMENT OF PATIENTS WITH ANTICOAGULANT THERAPY")
DENTAL MANAGEMENT OF PATIENTS WITH ANTICOAGULANT THERAPY39,99 €![Prise en charge dentaire des patients sous traitement anticoagulant]( "Prise en charge dentaire des patients sous traitement anticoagulant")
Prise en charge dentaire des patients sous traitement anticoagulant39,99 €![Pharmacology and Dental Implications of Novel Oral Anticoagulants]( "Pharmacology and Dental Implications of Novel Oral Anticoagulants")
Pharmacology and Dental Implications of Novel Oral Anticoagulants19,99 €![Prise en charge dentaire des patients sous traitement anticoagulant]( "Prise en charge dentaire des patients sous traitement anticoagulant")
Prise en charge dentaire des patients sous traitement anticoagulant39,99 €![OZONE THERAPY FOR THE MANAGEMENT OF PERIODONTAL DISEASE]( "OZONE THERAPY FOR THE MANAGEMENT OF PERIODONTAL DISEASE")
OZONE THERAPY FOR THE MANAGEMENT OF PERIODONTAL DISEASE29,99 €![Prevalence of Hepatitis B in Dental Patients]( "Prevalence of Hepatitis B in Dental Patients")
Prevalence of Hepatitis B in Dental Patients44,99 €![Dental Fear and Anxiety in Pediatric Patients]( "Dental Fear and Anxiety in Pediatric Patients")
Dental Fear and Anxiety in Pediatric Patients39,99 €
The treatment of patients taking anticoagulant or antiplatelet medication raises safety concerns in terms of the potential risk of bleeding complications following invasive dental procedures. The anticoagulant warfarin, and antiplatelet agents aspirin and clopidogrel, have been widely used for many years and most dental practitioners will be familiar with well-established guidelines for the dental care of patients taking these drugs. A lack of evidence in the context of dentistry to inform the treatment of patients taking these newer drugs has led to uncertainty around the appropriate management of these patients.